This supports the role of glucokinase as a β-cell glucose sensor that determines the capacity of the β-cell to take up glucose and oxidize it in the glycolytic pathway and led to the development of glucokinase activators as a potential treatment for diabetes (25). The gene discussed is GCK; the disease is diabetes mellitus.